Plus Therapeutics reported $62K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Baxter International USD 78M 20M Mar/2026
Cerus USD 2.33M 96K Jun/2024
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Haemonetics USD 5.08M 2.32M Mar/2026
Northwest Biotherapeutics USD 1.52M 276K Mar/2024
Plus Therapeutics USD 62K 25K Dec/2023
Sanofi EUR 287M 109M Jun/2026
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
Teva Pharmaceutical Industries USD 195M 21M Jun/2026